Short-term versus lifetime risk assessment for cardiovascular disease: Pros, cons, and clinical implications-Reference-Cited by-同舟云学术

Short-term versus lifetime risk assessment for cardiovascular disease: Pros, cons, and clinical implications

Published:2009-03 Issue:2 Volume:3 Page:144-149
ISSN:1932-9520
Container-title:Current Cardiovascular Risk Reports
language:en
Short-container-title:Curr Cardio Risk Rep

Author:

Wilkins John T.,Lloyd-Jones Donald M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s12170-009-0023-x.pdf

Reference32 articles.

1. Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25–e146.

2. Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997, 349:1498–1504.

3. Mokdad AH, Ford ES, Bowman BA, et al.: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76–79.

4. Jackson R: Guidelines on preventing cardiovascular disease in clinical practice. BMJ 2000, 320:659–661.

5. Rose G: Environmental health: problems and prospects. J R Coll Physicians Lond 1991, 25:48–52.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can cardiovascular disease guidelines that advise treatment decisions based on absolute risk be improved?;BMC Cardiovascular Disorders;2016-11-15

2. Coronary heart disease incidence in women by waist circumference within categories of body mass index;European Journal of Preventive Cardiology;2013-05-30

3. Impact of Blood Pressure and Blood Pressure Change During Middle Age on the Remaining Lifetime Risk for Cardiovascular Disease;Circulation;2012-01

4. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey;Drug Design, Development and Therapy;2011-06